Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) traded down 16.7% during trading on Monday . The company traded as low as $0.30 and last traded at $0.31. 1,723,207 shares changed hands during mid-day trading, an increase of 215% from the average session volume of 546,832 shares. The stock had previously closed at $0.37.
Shuttle Pharmaceuticals Stock Down 1.9 %
The firm has a market capitalization of $1.60 million, a price-to-earnings ratio of -0.06 and a beta of -1.04. The firm’s 50 day moving average is $0.49 and its 200 day moving average is $0.81.
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Read More
- Five stocks we like better than Shuttle Pharmaceuticals
- What Investors Need to Know to Beat the Market
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- What Are Earnings Reports?
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Growth Stocks: What They Are, Examples and How to Invest
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
